ATTO

Attovia Therapeutics, Inc. Common Stock

15.27

USD

+0.27

+1.80%

Nov 06, 15:59 UTC -5

Closed

After-Market

15.23

-0.04

-0.23%

Attovia Therapeutics, Inc. Common Stock (ATTO) Profile

Attovia Therapeutics, Inc. Common Stock Profile

About

Attovia Therapeutics Inc. is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. The company's lead programs include ATTO-1310, ATTO-2306 and ATTO-1091. Attovia Therapeutics Inc. is based in SAN CARLOS, Calif.

Info & Links

CEO

Tao Fu

Headquarters

1091 INDUSTRIAL ROAD
SAN CARLOS, CA 94070, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Attovia Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

695.50M

Enterprise Value

662.67M

Enterprise Value/EBITDA(ttm)

-30.39

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-1149.28%

Return on Equity(ttm)

Return on Invested Capital(ttm)

14.22%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

450.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

450.00K

EBITDA(ttm)³

-21.80M

Net Income Available to Common(ttm)

-20.69M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

14.03%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

45.65M

Dividend Yield

0.00%

Float⁴

45.20M

% Held by Insiders

0.99%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

115.13M

Total Cash Per Share(mrq)

2.52

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.39%

Quick Ratio(mrq)

9.39%

Book Value Per Share(mrq)

-32.12

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.24

Free Cash Flow(ytd)

-35.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.